Multiscale Functional Dysconnectivity Reveals Sex-Dominant Neurosubtypes and Predicts Unique Neurocognitive Pathways in Psychosis

Abstract

Psychotic disorders are severe mental conditions whose biological underpinnings remain elusive. This is in part due to marked heterogeneity, which may have precluded advances in precise understanding and treatment of the disorders. Previous work has tried to elucidate this heterogeneity; nevertheless, sex, as an important biological variable, has not been well accounted for despite established sex differences. Using resting-state fMRI data from the BSNIP consortium (N=1753; 64.3% probands with psychosis include 571 females and 556 males; 35.7% of controls includes 369 females and 257 males), we extracted multiscale functional network connectivity and employed unsupervised learning methods to identify potential subgroups with distinct neurobiological profiles, characterized by an overrepresentation of males or females (termed here as sex-dominant Psychosis Imaging Neurosubtypes, PINs). Four sex-dominant neurosubtypes emerged, two female-dominant (fPIN-1, fPIN-2) and two male-dominant (mPIN-1, mPIN-2). Each PIN exhibited distinct, replicable dysconnectivity patterns that uniquely contributed to cognitive deficits. Brain-Predicted Cognitive performance derived from these PIN-specific dysconnectivity, prominent among the triple network (default mode and salience), subcortical-basal ganglia, higher cognition-insular temporal, and visual-occipitotemporal subdomains, correlated with measured cognitive performance and showed PIN-specific reductions relative to controls, confirming neurosubtype-congruent associations. Moreover, fPIN-2's distinct dysconnectivity also predicted positive and negative symptom scores. Our findings lend support for sex-dominant neurobiological heterogeneity, with sex-dominant PINs presenting unique dysconnectivity patterns that contribute to cognitive and symptom outcomes, even though neurosubtypes appear clinically similar. These results establish sex as a critical biological variable in deconstructing psychosis heterogeneity, which holds promise in revealing more precise biomarkers for disease characterization and guiding personalized treatment strategies.